Consensus Aperam S.A.

Equities

APAM

LU0569974404

Market Closed - Euronext Amsterdam Other stock markets 11:35:59 2024-04-19 am EDT			5-day change	1st Jan Change
27.2 ^EUR	-0.87%		-6.98%	-17.27%

Apr. 02	Aperam: first sales of biochar on the Patch platform	CF
Mar. 07	Aperam: forthcoming delisting from BEL20	CF

Evolution of the average Target Price on Aperam S.A.

Price target over the last 5 years

History of analyst recommendation changes

1ce306e9abf9960abba8279859.-Zk_NocRGDQhtU9U339vOHEzjFdq3rfnPdFYx3WC6M4.y8hOAMQocwBm4w1njjQOCCZk5zAIsNHRcOY59RHnpKaX4HNk7WFyVm7PGg~f9ccf0bd27c373bbad1ab26b0bfb98c8

Analyst Recommendations on Aperam S.A.

APERAM : Integrating the FY23 with no change going forward	Feb. 14
APERAM : FY23 in line; some hopes for recovery (H2 24)?	Feb. 12
Oddo BHF Maintains Aperam at Neutral, Trims PT	Jan. 10	MT
APERAM : Oddo BHF slightly reduces its target	Jan. 10	CF
Oddo BHF Upgrades Aperam to Neutral from Underperform, Boosts PT	Nov. 27	MT
APERAM : Oddo BHF raises its opinion	Nov. 27	CF
Metals & Mining’s noticeable recovery	Nov. 17
APERAM : Q3 23: no miracle	Nov. 12
APERAM : Rather weak Q3 223 results for Aperam	Nov. 10
Miners’ sudden rebound – will it last?	23-09-18
Interesting (European) copper market dynamics	23-09-06
APERAM : Q2 23: when the going gets tough(er)	23-08-01
APERAM : When the going gets tough(er).	23-07-27
APERAM : (Very) minor adjustment to our numbers	23-07-13
ODDO BHF Downgrades Aperam to Underperformance from Neutral, Cuts PT	23-06-30	MT
Metals & Mining’s recent rebound – still not late to hop on	23-06-15
APERAM : We have fine-tuned our numbers after the Q123.	23-05-08
APERAM : A tougher environment.	23-05-03
Is it worth capitalising on the recent correction?	23-03-22
APERAM : FY22 more than OK, before an expected slow down in FY23/24	23-02-14
APERAM : Q322: a less favorable context	22-11-10
APERAM : Q2 22 results: solid in a less favorable context	22-07-29
Rumoured talks of a merger between Nornickel and Rusal	22-07-11
APERAM : Q1 22 fine with some doubts for H2	22-05-09
APERAM : A strong FY21 with a supportive Q1 22 outlook	22-02-11